Cigna vs Zoetis (CI vs ZTS)

Cigna (CI) vs Zoetis (ZTS) in plain English: P/E, growth, margins, debt and dividend side by side, key differences and which fits each investor profile.

Cigna (CI) and Zoetis (ZTS) compete in healthcare and pharma. Here are Cigna and Zoetis side by side with their real figures as of November 4, 2026: what sets them apart, which fits each kind of investor and the most common questions, without telling you whether to buy Cigna or Zoetis.

Cigna vs Zoetis: the figures

Cigna and Zoetis figures from Yahoo Finance, the same source the Fintols analysis uses, retrieved on November 4, 2026; N/A means that Cigna or Zoetis figure is not available, and we never estimate it.

3 key differences between Cigna and Zoetis

1. Profitability: for every 100 of sales, Zoetis keeps 27.7 as net profit and Cigna keeps 2.3.
2. Volatility: Zoetis stock moves more (beta 0.68) than Cigna (beta 0.25); the higher the beta, the more it amplifies market swings.
3. Growth: Cigna grew sales +6.7% year on year in its latest quarter, against -0.2% for Zoetis.

Cigna or Zoetis: which fits your profile

• If you want growth: Cigna is growing faster today, so it fits better with investors who put business growth first, usually accepting a higher P/E and a bumpier ride.
• If you want income (dividends): Zoetis pays the higher dividend relative to its price.
• If you prefer caution: Zoetis has less debt relative to its profit, which usually gives more room in a bad year.
• If price is what matters most to you: Cigna trades on the lower P/E; check first whether that is an opportunity or a sign of a business that grows less.

Neither Cigna nor Zoetis wins on everything, and owning both is also an option: spreading money across several companies or an index fund reduces what rides on each one.

How Cigna and Zoetis make money

Cigna (CI)

The Cigna Group has two main platforms. Evernorth Health Services, the larger by revenue, includes pharmacy benefit manager Express Scripts and specialty pharmacy Accredo, while Cigna Healthcare sells health coverage, mainly to employers insuring their workers. The vast majority of its business is in the United States. Full Cigna analysis.

Zoetis (ZTS)

Zoetis makes medicines, vaccines and diagnostics for animals. Companion animal products such as Simparica, Apoquel and Librela for dogs and cats bring in most of its sales, while livestock products treat cattle, pigs, poultry and fish. The company reports two segments: United States and International. Full Zoetis analysis.

Frequently asked questions: Cigna vs Zoetis

Is Cigna or Zoetis the better stock?

Choosing between Cigna and Zoetis depends on what you are looking for. Cigna is growing faster right now, and Cigna trades on the lower P/E. Fintols does not tell you whether to buy Cigna or Zoetis: it shows you the differences so you can decide.

Which pays a higher dividend, Cigna or Zoetis?

As of November 4, 2026, Zoetis yields 2.55% and Cigna yields 2.11%. Also check how much of their profit Cigna and Zoetis pay out: if it is more than they earn, it cannot last.

Which is more expensive, Cigna or Zoetis?

On P/E, Zoetis (14.7x) is more expensive than Cigna (12.6x) as of November 4, 2026. A higher P/E can be justified if earnings grow faster, so compare it with each company's growth in the table.

Can I own both Cigna and Zoetis?

Yes. Many people spread their money across several companies, such as Cigna and Zoetis, or use index funds so they do not depend on just one. If you are starting out, decide how much you want to invest and for how long before buying Cigna or Zoetis.

More comparisons with Cigna or Zoetis

• Cigna vs Elevance Health
• Cigna vs Regeneron
• Elevance Health vs Zoetis
• Regeneron vs Zoetis

More companies like Cigna and Zoetis: healthcare and pharma stocks. Educational content about Cigna and Zoetis, not investment advice.